BT Wealth Management’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-2,250
Closed -$409K 67
2021
Q1
$409K Sell
2,250
-4,000
-64% -$928K 0.14% 38
2020
Q4
$1.25M Buy
6,250
+2,442
+64% +$497K 0.46% 22
2020
Q3
$835K Buy
3,808
+1,008
+36% +$213K 0.36% 25
2020
Q2
$534K Hold
2,800
0.27% 32
2020
Q1
$434K Hold
2,800
0.25% 34
2019
Q4
$234K Buy
+2,800
New +$213K 0.12% 54

Other funds holding TDOC

BT Wealth Management's TDOC Position: Q2 2021 in Review

BT Wealth Management sold out of Teladoc Health (TDOC) in Q2 2021, closing a stake of 2,250 shares — an estimated $409K sold.

BT Wealth Management first reported a position in TDOC in Q4 2019 and held it in 6 quarters. The position peaked at $1.25M in Q4 2020. 829 funds tracked by Wall St. Rank hold TDOC as of Q2 2021.

  • BT Wealth Management reported no remaining Teladoc Health position as of Q2 2021 after selling out during the quarter.
  • BT Wealth Management sold 2,250 Teladoc Health shares in Q2 2021, an estimated $409K.
  • BT Wealth Management first reported a position in Teladoc Health in Q4 2019 and held it in 6 quarters.
  • BT Wealth Management's Teladoc Health position peaked at $1.25M in Q4 2020.
  • 829 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2021.

Based on BT Wealth Management's 13F filing for Q2 2021, filed 28 Jul 2021.